Filing Details
- Accession Number:
- 0001209191-17-060795
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-15 10:24:52
- Reporting Period:
- 2017-11-15
- Accepted Time:
- 2017-11-15 10:24:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1108205 | Curis Inc | CRIS | Biological Products, (No Disgnostic Substances) (2836) | 043505116 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1570026 | Ph.d. Ali Fattaey | C/O Curis, Inc. 4 Maguire Road Lexington MA 02421 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-11-15 | 50,000 | $1.06 | 115,890 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- These shares were purchased between $0.97-$1.11/share. The Company will provide, upon request, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
